English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Background Candida parapsilosis fungemia typically occurs in patients with intravascular catheters or prosthetic devices. In 2017, we noted an increase in C. parapsilosis infective endocarditis (IE). Methods We retrospectively reviewed C. parapsilosis fungemia and IE from January 2015 to February 2018. Species were identified using MALDI-TOF, and confirmed by ITS sequencing. Results Between 2010 and 2017, there was no increase in cases of C. parapsilosis fungemia (mean: 13/year), but there was a significant increase in C. parapsilosis IE (P = 0.048) (Figure 1). From January 2015 to February 2018, 22% (12/54) of C. parapsilosis fungemia was complicated by IE. Demographics of C. parapsilosis fungemia included: community-acquired infection (87%), presence of vascular catheters (80%), opiate noninjection drug use (non-IDU, 44%), IDU (20%), and presence of cardiac devices (18%). Ninety-one percent (49/54) of C. parapsilosis fungemia was caused by C. parapsilosis sensu strictu (Cpss); C. orthopsilosis and C. metapsilosis accounted for 4% (2/54) each (1 isolate could not be subtyped). Cpss, C. orthopsilosis, and C. metapsilosis accounted for 83% (10/12), 8% (1/12), and 8% (1/12) of IE, respectively. Ninety-two% (11/12) of C. parapsilosis IE was left-sided, and 33% (4/12) involved multiple valves. Risk factors for C. parapsilosis IE were past or active IDU (P < 0.001), community-acquired fungemia (P = 0.02), prosthetic heart valve (P = 0.01) or implanted cardiac device (P = 0.03). Receipt of an antibiotic within 30 days was a risk for C. parapsilosis fungemia without IE (P = 0.001). Median age for IE vs. fungemia was 38 vs. 57 years (P = 0.09). By multivariate logistic regression, IDU (P < 0.0001), prosthetic valve (P = 0.006) or implanted cardiac device (P = 0.04) were independent risks for C. parapsilosis IE. 70% (7/10), 20% (2/10), and 10% (1/10) of patients with IDU and C. parapsilosis IE primarily used heroin, buprenorphine/naltrexone, and cocaine, respectively. 50% (6/12) of patients with C. parapsilosis IE underwent surgery; most common initial AF regimens were caspofungin and amphotericin B. Nonsurgical patients were suppressed with long-term azole; one relapsed requiring surgery. Thirty-day and in-hospital mortality for patients with fungemia vs. IE were 32% vs. 17% and 26% vs. 17%, respectively. Conclusion C. parapsilosis IE has emerged at our center. Unique aspects of C. parapsilosis pathogenesis that may account for emergence are a propensity to colonize skin, adhere to prosthetic material and form biofilm. C. parapsilosis IE may be an under-appreciated consequence of IDU and opioid abuse. Disclosures All authors: No reported disclosures.

383. An Increased Rate of Candida parapsilosis Infective Endocarditis Is Associated With Injection Drug Use